LB制药 LBRX
$42.01 +$3.92 (+10.29%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $42.50 +1.17%
开盘$38.53
昨收$38.09
当日区间$38.04 – $42.29
成交量480.3K
市值$1.36B
市盈率（TTM）41.4
股息率–
LBRX 相关新闻
匹配 LB Pharmaceuticals 或代码 LBRX 的头条新闻，按最新排序。
- Piper Sandler Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $78
- Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX) and SpaceX (SPCX)
- H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $60 正面
- Clear Street Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $69
- Clear Street Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $69 正面
- Stifel Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $53 正面
- Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX), LB Pharmaceuticals, Inc. (LBRX) and BETA Technologies, Inc. Class A (BETA)
- Craig-Hallum Remains a Buy on LB Pharmaceuticals, Inc. (LBRX)
- Earnings Flash (LBRX) LB Pharmaceuticals Posts Q2 Loss $1.71 a Share, Vs. FactSet Est of $0.81 Loss 负面
- Wolfe Research Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $45
- Analysts Offer Insights on NA Companies: Exodus Movement, Inc. Class A (EXOD) and LB Pharmaceuticals, Inc. (LBRX)
- LB Pharmaceuticals, Inc. (LBRX) Gets a Buy From H.C. Wainwright
- Craig-Hallum Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $36
- Clear Street Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $45
暂无评论——快来第一个聊聊 LBRX。
登录后参与讨论。